These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 23156402)

  • 1. [Involvement of chronic inflammation in chronic diseases and diabetic complications].
    Manabe I
    Nihon Rinsho; 2012 Jul; 70 Suppl 5():248-52. PubMed ID: 23156402
    [No Abstract]   [Full Text] [Related]  

  • 2. Association of abdominal visceral adiposity and thigh sarcopenia with changes of arteriosclerosis in haemodialysis patients.
    Kato A; Ishida J; Endo Y; Takita T; Furuhashi M; Maruyama Y; Odamaki M
    Nephrol Dial Transplant; 2011 Jun; 26(6):1967-76. PubMed ID: 20980356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease.
    Wang MC; Tsai WC; Chen JY; Huang JJ
    Am J Kidney Dis; 2005 Mar; 45(3):494-501. PubMed ID: 15754271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Para- and perirenal fat thickness is an independent predictor of chronic kidney disease, increased renal resistance index and hyperuricaemia in type-2 diabetic patients.
    Lamacchia O; Nicastro V; Camarchio D; Valente U; Grisorio R; Gesualdo L; Cignarelli M
    Nephrol Dial Transplant; 2011 Mar; 26(3):892-8. PubMed ID: 20798120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Inflammation and vascular calcifications].
    Six I; Massy ZA
    Nephrol Ther; 2010 Feb; 6 Suppl 1():S13-8. PubMed ID: 20172495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The emerging biology of adipose tissue in chronic kidney disease: from fat to facts.
    Axelsson J
    Nephrol Dial Transplant; 2008 Oct; 23(10):3041-6. PubMed ID: 18632589
    [No Abstract]   [Full Text] [Related]  

  • 7. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.
    Kim W; Hudson BI; Moser B; Guo J; Rong LL; Lu Y; Qu W; Lalla E; Lerner S; Chen Y; Yan SS; D'Agati V; Naka Y; Ramasamy R; Herold K; Yan SF; Schmidt AM
    Ann N Y Acad Sci; 2005 Jun; 1043():553-61. PubMed ID: 16037278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular assessment of diabetic end-stage renal disease patients before renal transplantation.
    Welsh RC; Cockfield SM; Campbell P; Hervas-Malo M; Gyenes G; Dzavik V
    Transplantation; 2011 Jan; 91(2):213-8. PubMed ID: 21048531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes and kidney disease.
    Ulrich B
    Nephrol Nurs J; 2009; 36(5):461. PubMed ID: 19856806
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of the gut in visceral fat inflammation and metabolic disorders.
    Lam YY; Mitchell AJ; Holmes AJ; Denyer GS; Gummesson A; Caterson ID; Hunt NH; Storlien LH
    Obesity (Silver Spring); 2011 Nov; 19(11):2113-20. PubMed ID: 21881620
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of concomitant diabetes and chronic kidney disease on preload-induced changes in left ventricular diastolic filling in hypertensive patients.
    Iwashima Y; Horio T; Suzuki Y; Takagi T; Kamide K; Ohishi M; Ogihara T; Yoshikawa J; Kawano Y; Rakugi H
    J Hypertens; 2011 Jan; 29(1):144-53. PubMed ID: 20881868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary dysfunction is possibly a marker of malnutrition and inflammation but not mortality in patients with end-stage renal disease.
    Yoon SH; Choi NW; Yun SR
    Nephron Clin Pract; 2009; 111(1):c1-6. PubMed ID: 19023220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver fat in obesity: role of type 2 diabetes mellitus and adipose tissue distribution.
    Bozzetto L; Prinster A; Mancini M; Giacco R; De Natale C; Salvatore M; Riccardi G; Rivellese AA; Annuzzi G
    Eur J Clin Invest; 2011 Jan; 41(1):39-44. PubMed ID: 20825466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The metabolic syndrome, diabetes and lung dysfunction.
    Tiengo A; Fadini GP; Avogaro A
    Diabetes Metab; 2008 Nov; 34(5):447-54. PubMed ID: 18829364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ectopic fat depots and cardiovascular disease.
    Britton KA; Fox CS
    Circulation; 2011 Dec; 124(24):e837-41. PubMed ID: 22156000
    [No Abstract]   [Full Text] [Related]  

  • 16. Fat fuels the flame: triglyceride-rich lipoproteins and arterial inflammation.
    Libby P
    Circ Res; 2007 Feb; 100(3):299-301. PubMed ID: 17307968
    [No Abstract]   [Full Text] [Related]  

  • 17. The heterogeneity of diabetes: unraveling a dispute: is systemic inflammation related to islet autoimmunity?
    Pietropaolo M; Barinas-Mitchell E; Kuller LH
    Diabetes; 2007 May; 56(5):1189-97. PubMed ID: 17322478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drosophila: a model for understanding obesity and diabetic complications.
    Teleman AA; Ratzenböck I; Oldham S
    Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):184-5. PubMed ID: 22402943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Incidence and clinical characteristics of renal insufficiency in diabetic patients].
    Schwenger V; Müssig C; Hergesell O; Zeier M; Ritz E
    Dtsch Med Wochenschr; 2001 Nov; 126(47):1322-6. PubMed ID: 11719856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of total energy expenditure from all levels of physical activity vs. physical activity energy expenditure from moderate-to-vigorous activity on visceral fat and insulin sensitivity in obese Type 2 diabetic women.
    Koo BK; Han KA; Ahn HJ; Jung JY; Kim HC; Min KW
    Diabet Med; 2010 Sep; 27(9):1088-92. PubMed ID: 20722686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.